Expression and functional role of negative signalling regulators in tumour development and progression.
about
Role and expression of FRS2 and FRS3 in prostate cancerComplexity of receptor tyrosine kinase signal processing.The MAPK pathway across different malignancies: a new perspective.Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cellsKIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.Sprouty2 correlates with favorable prognosis of gastric adenocarcinoma via suppressing FGFR2-induced ERK phosphorylation and cancer progression.Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer.Crosstalk signaling in targeted melanoma therapy.FGFs: crucial factors that regulate tumour initiation and progression.Downregulation of Sprouty homolog 2 by microRNA-21 inhibits proliferation, metastasis and invasion, however promotes the apoptosis of multiple myeloma cells.Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer.Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancerCooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.Hair follicle dermal condensation forms via Fgf20 primed cell cycle exit, cell motility, and aggregation
P2860
Q21261288-8ABDE13F-9F7D-442E-BF5F-8E30759369DAQ34361161-60AD8368-C63A-4693-A4AB-6D32C0764C75Q34459097-BB02FDA9-AF38-4519-80CC-08615984E115Q35092057-4DB70C10-457B-42B9-ADD5-4CF5387AA4C0Q35751428-0AAF3838-061B-4EDA-A10B-2B983D3E7A25Q37706271-C98A10CE-625A-4E2E-8D49-D7F12785C1F8Q38722079-38017DC7-45C0-4AA3-9308-0AF5372B151BQ38757522-E1F82ADE-8C80-4C04-95A0-A76909365BA9Q38887615-D8D4A61D-8FEF-484B-845A-A4AAB89EAACFQ38892834-808FB607-E0E5-456F-88F7-7D916055479CQ39697330-7AEE8145-0284-4F5A-9298-53EBF78BC318Q41348763-4EA56513-BA27-44A9-AD6E-3C2998ED720BQ47252408-D13CC78E-EB34-40B6-8257-E6C741B95557Q50965411-417E89DA-C5B4-49F3-BF3E-4FB5288BF80BQ56530756-A5173148-4A14-486E-9C1C-99FF7AA45D08
P2860
Expression and functional role of negative signalling regulators in tumour development and progression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression and functional role ...... r development and progression.
@ast
Expression and functional role ...... r development and progression.
@en
Expression and functional role ...... r development and progression.
@nl
type
label
Expression and functional role ...... r development and progression.
@ast
Expression and functional role ...... r development and progression.
@en
Expression and functional role ...... r development and progression.
@nl
prefLabel
Expression and functional role ...... r development and progression.
@ast
Expression and functional role ...... r development and progression.
@en
Expression and functional role ...... r development and progression.
@nl
P2093
P2860
P356
P1476
Expression and functional role ...... ur development and progression
@en
P2093
Satoshi Hori
Tania Murphy
Vincent J Gnanapragasam
P2860
P304
P356
10.1002/IJC.25542
P50
P577
2010-12-01T00:00:00Z